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The amount of amoxicillin in pharmaceutical formulations was
determined using spectra of diffuse reflectance infrared Fourier
transform spectroscopy (DRIFTS), in association with partial least
squares (PLS) regression. The spectra of 24 different samples (17
for the calibration set and 7 for the validation set), which had
been registered using a Nicolet Magna 550 spectrophotometer,
contained 76.7-94.3% of amoxicillin in starch. The PLS models
were constructed with auto-scaled or variance-scaled data, and
multiplicative scatter correction (MSC). The best model presented
R2=0.9936, RMSEC=0.441 and RMSEV=0.790. The analytical
method proposed is non-destructive and the cost and time of
analysis are very much reduced, allowing for the fast and direct
determination of amoxicillin content.
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The integration of the manufacturing sector with the
quality control of pharmaceutical drugs plays a crucial role
in guaranteeing that good practices will be used for the
procurement of pharmaceutical end products, thus
providing patients with excellent quality formulations.
Instrumentation analytical methods that are neither
destructive nor produce residues have been increasingly
investigated for the identification and quantification of
active ingredients, using infrared spectroscopy (Blanco et
al., 2000a; Blanco et al., 2000b; Blanco et al., 2001;
Braga, Poppi, 2004; Pasquini, 2003; Sun, Xiang, An,
2004; Yang, Irudayaraj, 2002).
Even though liquid chromatography is the official
method for the quantification of amoxicillin in capsules or in
oral solutions, according to a pharmacopoeia monograph
(USP, 2002), several alternatives have been proposed in the
literature for the identification and quantification of
amoxicillin in human tissues (e.g. plasma) or even in drug
formulas. Hernández, Borrull and Calull (1999) developed
a method using capillary electrophoresis in order to determi-
ne amoxicillin content in animal plasma samples, since many
veterinary drugs, such as amoxicillin, are used to treat
animals for food production. A quick routine analytical
procedure for the identification and quantification of
premixtures of amoxicillin was developed and tested by
Dousa and Hosmanová (2005) using reverse phase high
performance liquid chromatography (HPLC). This method
proved to be selective and can be used in routine analyses,
allowing for the distinction between amoxicillin and other
penicillins, which have similar structures. Hoizey et al.
(2002) and Yoon et al. (2004) used reverse phase HPLC for
the simultaneous determination of amoxicillin and clavulanic
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acid in human plasma, whereas Hoizey used HPLC with
ultraviolet detection and Yoon improved the method by
employing HPLC combined with mass spectroscopy. Both
methods were simple and accurate. Quite recently,
Pasamontes and Callao (2004) described a quick method for
the determination of pharmaceutical forms of amoxicillin in
the presence of interferents, with inexpensive reagents and
tools, and no need for sample pretreatment using sequential
injection analysis with a diode array spectrophotometer and
multivariate curve resolution.
The interface between chemometric tools and the data
obtained by infrared methods offers new possibilities for
the quantification and qualification of pharmaceutical
drugs (Blanco et al., 2000a; Blanco et al., 2000b; Blanco
et al., 2001; Pasquini, 2003; Yang, Irudayaraj, 2002; Fer-
rão, Davanzo, 2005). On top of that, because it is a simple,
easily obtained and non-destructive method, its procedures
are appropriate for pharmaceutical formulations. Such
methods have allowed to compare (Sabin, Ferrão, Furtado,
2004; Neumann et al., 2004, De Souza et al., 2004) and
quantify (Blanco et al., 2000b; Blanco et al., 2001; Yang,
Irudayaraj, 2002; Sun, Xiang, An, 2004; Konzen et al.,
2003) several drugs during different manufacturing stages.
Partial least squares regression (PLS)
In the PLS regression model, developed by Herman
Wold (Wold, 1978; Sjöström et al., 1983; Swierenga et al.,
1999; Brereton, 2000), the spectral information and the
concentrations are used simultaneously in the calibration
phase.
The mainstay of PLS is the decomposition of the
matrix of data X in terms of the sum of h matrices M plus
a vector of residues e (corresponding to the error), as shown
in equation 1. Matrices M are called latent variables (LVs)
and h is the number of latent variables used to construct the
model.
(1)
Basically, a matrix containing the absorbance of the
infrared spectra of standards (X) is associated with another
matrix that stores data on its concentration (y), resulting in
equations 2 and 3, in which T and U are scores of X and y
respectively, and P and Q are the loadings. Matrices E and
F represent the modeling errors of X and y.
(2)
(3)
The correlation between variables X and y is a line-
ar relationship obtained through linear regression
coefficients, as shown in equation 4.
(4)
After being calculated, h values bh are grouped in a
diagonal matrix B, which contains the regression
coefficients between score matrices U of y and T of X. To
find the best linear relationship between the scores of these
two matrices, small rotations of the latent variables are
carried out. Finally, we have equation 5, where y is
calculated using the matrix of scores T, the regression
coefficient matrix B, the matrix of loadings Q and the
matrix of residues F.
(5)
To calculate the concentration of new samples, one




Preprocessing is a column-oriented operation so
preprocessing results are specific for a set of samples.
Adding a sample to a data set can greatly influence the
effect of a preprocessing technique. The difference between
preprocessing data on a variable-basis and transforming
data on a sample-basis is important to appreciate.
Preprocessing is necessary because several multivariate
algorithms compute results driven by variance patterns in
the independent variables. Sometimes arbitrary
measurement scales and/or magnitudes produce misleading
results when an inappropriate preprocessing is made. The
preprocessing procedures most common are mean-
centering, variance scaling, auto-scaling and range scaling
(Infometrix, 2003). In this work we used the auto-scaling
and variance scaling algorithms.
Mean-center
A mean is computed for each variable (j) via the
equation 7.
(7)
The mean is then subtracted from each data value (i)
to produce a mean-centered matrix according to equation 8.
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(8)
Variance scale
When data from two (or more) disparate variables
span different magnitude ranges, the largest variable
dominates any variance computations. In such situations,
the dominant variable’s masking influence can be removed
by variance scaling.
For preprocessing spectra data, first compute the
variance for each variable (j) via the equation 9.
(9)
Then, each independent variable is divided by the




Auto-scaling finds use in many fields including
spectra data preprocessing. For these applications, auto-





Through an experimental planning, 24 standard
samples of amoxicillin were mixed into starch, of which 17
had been used for calibration and 7 for validation. This
active ingredient was manipulated so as to provide a set of
samples with different concentrations between 76.7-94.3 %
(w/w).
DRIFT spectra and data processing
A Nicolet Magna 550 FTIR spectrophotometer with
a 4 cm-1 resolution and 32 scans was used for the
measurement of amoxicillin content in the samples.
Duplicate spectra were recorded by a Pike DRIFTS
accessory (Figure 1).
A partial least squares (PLS) regression analysis for
the DRIFT spectra of the 17 samples was carried out using
Pirouette software (Infometrix, 2003). The PLS models
were developed using DRIFTS data in five different
regions, as shown in Figure 2 (3,666-3,000; 3,000-2,650;
2,100-1,750; 1,750-1,530 and 1,530-950 cm-1). PLS
models were built with auto-scaled (mean-centered and
variance-scaled methods were applied) and/or
multiplicative scatter correction (MSC). The samples
presenting extreme amoxicillin content were included in the
calibration set.
FIGURE 1 - DRIFT spectrum set of amoxicillin samples.
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Cross-validation following the leave-one-out
procedure was performed during the validation step in
order to define the optimum number of factors that should
be kept in the model and to detect any outliers.
Seven new spectra were used in duplicate for the
validation of the PLS regression model. The best model was
selected considering the minimal error, that is, minor
RMSEC (Root Mean Square Error of Calibration) and
minor RMSEV (Root Mean Square Error of Validation)
described in equation 12.
 (12)
where n is the number of spectra, yi and ^yi are the values for
standard amoxicillin samples mixed with starch and those
predicted by the DRIFTS/PLS model, respectively, in the
calibration set or external validation set.
RESULTS AND DISCUSSION
Initially, each of the five regions was assessed
separately and the RMSECV values were calculated for the
DRIFTS/PLS models, as shown in Figures 3 and 4. After
that, new DRIFTS/PLS models were constructed by
combining the regions with the lowest RMSECV values
with the other ones (Sutter, Kalivas, 1993). This procedure
was repeated until the RMSECV value no longer decreased
with the introduction of new spectral regions.
FIGURE 2 - Subtraction between the spectra of samples with high and low concentrations of amoxicillin in selected
subregions.
FIGURE 3 - Cross-validated prediction errors (RMSECV)
for 5 interval models (bars) and combined subregion-
spectrum model (dashed line) for amoxicillin determination
using auto-scaled data and MSC.
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All the built models had a lower error level when
multiplicative scatter correction (MSC) was used.
Finally, the regression models with the lowest
RMSECV values were compared to those that combined
the five regions, as shown in Tables I and II, using auto-
scaled and variance-scaled data, respectively.
Seven samples were selected as test samples for the
different preprocessing data. In both Tables (I and II), the
models using only two subregions present better predictions
with lower error in relation to the total combined subregion
models.
The two preprocessing data used for the construction
of the models yielded satisfactory results. The best
RMSEC, RMSEV and R2 results of the best models using
auto-scaled and variance-scaled data are shown in Figures
5 and 6, respectively.FIGURE 4 - Cross-validated prediction errors (RMSECV)
for 5 interval models (bars) and combined subregion-
spectrum model (dashed line) for amoxicillin determination
using variance-scaled data and MSC.
TABLE I - Avarege prediction results for the calibration models for amoxicillin using auto-scaled data and MSC
Reference (%) Total Combined Subregion Model Combined Subregion Model
3,666-2,650 and 2,100-965 cm-1 3,000-2,650 and 2,100-1,750 cm-1
Predicted (%) Residual (%) Predicted (%) Residual (%)
78.59 78.58 ± 0.97 0.01 78.25 ± 0.50 0.34
80.63 81.14 ± 1.42 -0.51 81.55 ± 0.66 -0.92
82.74 82.64 ± 0.07 0.10 82.61 ± 0.15 0.13
84.96 84.92 ± 0.42 0.04 84.21 ± 0.20 0.75
87.35 87.02 ± 0.15 0.33 86.97 ± 0.62 0.37
89.83 91.91 ± 0.93 -2.08 90.86 ± 0.95 -1.03
92.49 91.18 ± 1.59 1.31 91.85 ± 0.62 0.64
RMSEP 0.958 0.671
LVs 5 5
TABLE II  - Average prediction results for the calibration models for amoxicillin using variance scaled data and MSC
Reference (%) Total Combined Subregion Model Combined Subregion Model
3,666-2,650 and 2,100-965 cm-1 2,100-1,750 and 1,750-1,530 cm-1
Predicted (%) Residual (%) Predicted (%) Residual (%)
78.59 78.74 ± 0.15 -0.16 78.16 ± 0.03 0.43
80.63 80.68 ± 1.17 -0.05 81.26 ± 0.95 -0.62
82.74 82.52 ± 0.02 0.22 83.24 ± 0.23 -0.50
84.96 84.73 ± 0.66 0.23 84.85 ± 0.40 0.11
87.35 87.48 ± 0.54 -0.13 87.61 ± 0.40 -0.27
89.83 91.18 ± 0.66 -1.35 90.80 ± 0.64 -0.97
92.49 91.21 ± 1.63 1.27 91.43 ± 1.29 1.06
RMSEP 0.716 0.650
LVs 4 4
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CONCLUSIONS
In the present study, we may verify that the DRIFTS
technique associated with the PLS calibration algorithm is a
solution to the problem with the quantification of amoxicillin
in samples obtained in manufacturing processes. Better
models could be obtained by using auto-scaled or variance-
scaled data, with the advantage of selecting chemically
significant bands. The advantages of these methodologies are
that they are non-destructive, have a lower cost, and do not
produce residues. Therefore, they may yield excellent results
when applied to the quality control of drugs, either at the
industrial level or in the control of manufacturing processes
at compounding pharmacies.
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RESUMO
Determinação de amoxicilina em formulações farma-
cêuticas em pó empregando DRIFTS-PLS
Neste trabalho propõe-se a quantificação de amoxicilina
em formulações farmacêuticas empregando espectros-
copia por refletância difusa no infravermelho com trans-
formada de Fourier (DRIFTS) e regressão por mínimos
quadrados parciais (PLS). Foram coletados em um
espectrômetro Nicolet Magna 550 os espectros de 24
amostras (17 para o conjunto de calibração e 7 para o
conjunto de validação) contendo de 76,7-94,3 % de
amoxicilina em amido. Para a construção dos modelos
PLS foi empregada a correção do espalhamento de luz
(MSC) e os dados foram autoescalados ou escalados pela
variância. Foi obtido um excelente modelo para a previ-
são da amoxicilina o qual apresentou R2=0,9936,
RMSEC=0,441 e RMSEV=0,790. O método proposto
além de não destrutivo apresenta baixo tempo de análise
e baixo custo podendo ser facilmente empregado no con-
trole de qualidade das indústrias farmacêuticas.
UNITERMOS: Regressão multivariada. Regressão por
mínimos quadrados parciais. DRIFTS. Amoxicilina.
Quimiometria.
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